Russell Investments Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-87,136
| Closed | -$530K | – | 3175 |
|
|
2021
Q3 | $530K | Sell |
87,136
-1,386
| -2% | -$8.64K | ﹤0.01% | 2434 |
|
|
2021
Q2 | $727K | Buy |
88,522
+24,555
| +38% | +$209K | ﹤0.01% | 2450 |
|
|
2021
Q1 | $571K | Sell |
63,967
-20,077
| -24% | -$230K | ﹤0.01% | 2470 |
|
|
2020
Q4 | $968K | Buy |
+84,044
| New | +$977K | ﹤0.01% | 2129 |
|
|
2020
Q3 | – | Sell |
-2,148
| Closed | -$28K | – | 3295 |
|
|
2020
Q2 | $28K | Sell |
2,148
-39,340
| -95% | -$408K | ﹤0.01% | 3032 |
|
|
2020
Q1 | $325K | Buy |
+41,488
| New | +$625K | ﹤0.01% | 2359 |
|
|
2018
Q1 | – | Sell |
-4,592
| Closed | -$119K | – | 3042 |
|
|
2017
Q4 | $119K | Sell |
4,592
-122,838
| -96% | -$3.01M | ﹤0.01% | 2748 |
|
|
2017
Q3 | $3.08M | Buy |
127,430
+122,450
| +2,459% | +$2.88M | 0.01% | 1535 |
|
|
2017
Q2 | $101K | Sell |
4,980
-26,826
| -84% | -$559K | ﹤0.01% | 2806 |
|
|
2017
Q1 | $856K | Sell |
31,806
-5,727
| -15% | -$117K | ﹤0.01% | 2180 |
|
|
2016
Q4 | $715K | Buy |
+37,533
| New | +$717K | ﹤0.01% | 2334 |
|
Russell Investments Group's FLXN Position: Q4 2021 in Review
Russell Investments Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 87,136 shares — an estimated $530K sold.
Russell Investments Group first reported a position in FLXN in Q4 2016 and held it in 11 quarters. The position peaked at $3.08M in Q3 2017. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.
- Russell Investments Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
- Russell Investments Group sold 87,136 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $530K.
- Russell Investments Group first reported a position in Flexion Therapeutics, Inc. in Q4 2016 and held it in 11 quarters.
- Russell Investments Group's Flexion Therapeutics, Inc. position peaked at $3.08M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.
Based on Russell Investments Group's 13F filing for Q4 2021, filed 21 Jan 2022.